Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 79Multiple Myeloma 73Prostatic Neoplasms 66Neoplasms 50Lymphoma 45Leukemia, Myeloid, Acute 44Neoplasm Metastasis 39Melanoma 39Lymphoma, Non-Hodgkin 34Ovarian Neoplasms 33Lung Neoplasms 32Squamous Cell Carcinoma of Head and Neck 31Hematologic Neoplasms 29Leukemia, Lymphocytic, Chronic, B-Cell 28Colorectal Neoplasms 27Hodgkin Disease 24Triple Negative Breast Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Sarcoma 20Fallopian Tube Neoplasms 20Pancreatic Neoplasms 19Carcinoma, Renal Cell 19Lymphoma, Mantle-Cell 18Lymphoma, Follicular 18Glioma 18Recurrence 17Leukemia 17Head and Neck Neoplasms 17

Interventions

Pharmacogenomic Testing 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Chondrosarcoma, Clear Cell × 90 days × Clear all
NCT01267955 2026-04-13

Vismodegib in Treating Patients With Advanced Chondrosarcomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting
45 enrolled 10 charts
Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡